Ballentine Partners’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
FAM
CAM
AC
GIA
PL
CCM
BG
Ballentine Partners's STE Position: Q2 2026 in Review
Ballentine Partners reduced its Steris (STE) stake by 25% in Q2 2026, selling an estimated $120K and leaving 1,724 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #697.
Ballentine Partners first reported a position in STE in Q2 2024 and has held it in 8 quarters since. The position peaked at $506K in Q1 2026. 93 funds tracked by Wall St. Rank hold STE as of Q2 2026.
- Ballentine Partners held 1,724 shares of Steris worth $363K as of Q2 2026.
- Ballentine Partners sold 562 Steris shares in Q2 2026, an estimated $120K.
- Steris made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #697 holding.
- Ballentine Partners first reported a position in Steris in Q2 2024 and has held it in 8 quarters since.
- Ballentine Partners's Steris position peaked at $506K in Q1 2026.
- 93 funds tracked by Wall St. Rank held Steris as of Q2 2026.
Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.